Inovio sets new timeline for its experimental Covid-19 vaccine
Plymouth Meeting's Inovio Pharmaceuticals provides an updated timeline for its experimental Covid-19 vaccine and says it expects to play an important role in the battle against the coronavirus. On Monday, Inovio began phase-II testing of its DNA-based Covid-19 vaccine candidate, INO-4800.
View the full story here: https://www.bizjournals.com/philadelphia/news/2020/12/08/inovio-covid-19-vaccine-candidate-ino-4800.html